Coherent Appoints Dr. Christopher Dorman As Executive VP, Lasers Business

Rhea-AI Summary

Coherent Corp. (NYSE: COHR) announces Dr. Christopher Dorman as Executive VP, Lasers Business. Dr. Dorman, with 21 years of tenure and expertise in laser technology, will lead the Lasers Segment, focusing on precision manufacturing, semiconductor & display capital equipment, life sciences, and scientific instruments. His role aims to drive operational excellence and customer focus, continuing to generate revenue and cash for the lasers business.

Positive

• Dr. Dorman's extensive experience and expertise in laser technology make him a strong choice to lead the Lasers Segment, which could potentially lead to increased innovation and market competitiveness.
• His track record of driving revenue and cash generation for the lasers business suggests a positive outlook for Coherent Corp.'s financial performance in the future.

Negative

• None.

PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in materials, networking, and lasers, today announced that Dr. Christopher Dorman has been named Executive Vice President, Lasers Business. In this position, he is responsible for the Lasers Segment across the markets of precision manufacturing, semiconductor & display capital equipment, life sciences, and scientific instruments, driving operational excellence and customer focus.

“Dr. Dorman’s 21-year tenure with Coherent and his recognized expertise in laser technology make him the perfect choice to lead multiple businesses within our Lasers Segment,” said Dr. Vincent D. Mattera, Jr., Chair and CEO. “Dr. Dorman established the blueprint for our world-class facilities for laser design and manufacturing in Glasgow, Kaiserslautern, and Lübeck, and in his new role he will continue to drive revenue and cash generation for our lasers business.”

Dr. Dorman was most recently Senior Vice President and General Manager based in Coherent’s state-of-the-art facility in Glasgow, Scotland. He joined Coherent in 2002 as a product manager and has held various positions as a general manager and vice president.

Dr. Dorman graduated from Oxford University with an MA (Oxon) in Physics and holds a Ph.D. in Lasers and Quantum Physics from Imperial College, London. He is currently Chair of the UK Photonics Leadership Group, Chair of Photonics Scotland, a visiting professor to the University of Strathclyde, and a Fellow of the Institute of Physics. He was recognized by Queen Elizabeth II with an OBE (Officer of the Most Excellent Order of the British Empire) for services to photonic and laser technology and exports in the 2019 Birthday Honours list.

About Coherent

Coherent empowers market innovators to define the future through breakthrough technologies, from materials to systems. We deliver innovations that resonate with our customers in diversified applications for the industrial, communications, electronics, and instrumentation markets. Headquartered in Saxonburg, Pennsylvania, Coherent has research and development, manufacturing, sales, service, and distribution facilities worldwide. For more information, please visit us at www.coherent.com.

Contact

Mark Lourie
Vice President, Corporate Communications
corporate.communications@coherent.com 

FAQ

What is the role of Dr. Christopher Dorman at Coherent Corp. (NYSE: COHR)?

Dr. Christopher Dorman has been named Executive Vice President, Lasers Business at Coherent Corp., where he will lead the Lasers Segment focusing on precision manufacturing, semiconductor & display capital equipment, life sciences, and scientific instruments.

What are Dr. Dorman's qualifications and experience?

Dr. Dorman has 21 years of tenure with Coherent and expertise in laser technology. He holds a Ph.D. in Lasers and Quantum Physics from Imperial College, London, and has been recognized by Queen Elizabeth II with an OBE for services to photonic and laser technology and exports.

What is the potential impact of Dr. Dorman's appointment on Coherent Corp.'s financial performance?

Dr. Dorman's appointment could potentially lead to increased innovation and market competitiveness, driving revenue and cash generation for Coherent Corp's lasers business, indicating a positive outlook for the company's financial performance in the future.